Skip to main content

Search

3 result(s) for 'author#Oliver Bähr' within BMC

Page 1 of 1

Sort by: Relevance | Date

  1. One quarter to one third of patients eligible for systemic thrombolysis are on antiplatelet therapy at presentation. In this study, we aimed to assess the safety and efficacy of intravenous thrombolysis in str...

    Authors: Benedikt M. Frey, Florent Boutitie, Bastian Cheng, Tae-Hee Cho, Martin Ebinger, Matthias Endres, Jochen B. Fiebach, Jens Fiehler, Ian Ford, Ivana Galinovic, Alina Königsberg, Josep Puig, Pascal Roy, Anke Wouters, Tim Magnus, Vincent Thijs…
    Citation: Neurological Research and Practice 2020 2:40
    Content type: Research article Published on:

  2. Hereditary diffuse leukodystrophy with spheroids is a rare type of leukoencephalopathy. Mutations in the colony stimulating factor 1 receptor have recently been identified to be the cause of this microgliopath...

    Authors: Marie Meyer-Ohlendorf, Anne Braczynski, Omar Al-Qaisi, Florian Gessler, Saskia Biskup, Lutz Weise, Joachim P. Steinbach, Marlies Wagner, Michel Mittelbronn and Oliver Bähr
    Citation: BMC Neurology 2015 15:103
    Content type: Case report Published on:

  3. Even in the presence of oxygen, malignant cells often highly depend on glycolysis for energy generation, a phenomenon known as the Warburg effect. One strategy targeting this metabolic phenotype is glucose res...

    Authors: Gabriele D Maurer, Daniel P Brucker, Oliver Bähr, Patrick N Harter, Elke Hattingen, Stefan Walenta, Wolfgang Mueller-Klieser, Joachim P Steinbach and Johannes Rieger
    Citation: BMC Cancer 2011 11:315
    Content type: Research article Published on: